Quantcast
Last updated on April 16, 2014 at 17:27 EDT

Latest Novo Nordisk Inc. Stories

2014-01-30 12:28:13

PRINCETON, N.J., Jan. 30, 2014 /PRNewswire/ -- Novo Nordisk (NYSE: NVO), a global healthcare company with 90 years of innovation and leadership in diabetes care, announced the promotion of Eddie Williams to senior vice president of biopharmaceuticals, effective February 1, 2014. (Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO) "Our biopharmaceutical business will be increasingly important to our growth in the U.S. as we apply the protein expertise developed through...

2013-11-01 08:27:52

Contest raises $35,000 in donations to local diabetes-related organizations PLAINSBORO, N.J, Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that Walton Kelly from Thomaston, Georgia, is the grand prize winner of the NovoLog® Community Star contest. The contest was held earlier this year to recognize patients with type 2 diabetes who use NovoLog® (insulin aspart [rDNA origin] injection) to help manage their blood sugar and give back to their local...

2013-09-09 12:27:14

First-in-Kind Alliance Sets Out to Break Taboo Around "Silent Symptom" of Menopause PLAINSBORO, N.J., Sept. 9, 2013 /PRNewswire/ -- As many as 75 percent of women who have gone through menopause are living with vaginal dryness, a bothersome symptom that they feel is negatively affecting their quality of life.([1,2]) Despite the high prevalence, only 25 percent of women with vaginal dryness will take action to resolve it.([1]) To address this, five leading women's health advocates today...

2013-05-08 08:30:39

PRINCETON, N.J., May 8, 2013 /PRNewswire/ -- Novo Nordisk announced that a new survey of women on local estrogen therapy revealing key insights into reasons for treatment non-compliance was published in the International Journal of Women's Health. The study, "Improved Compliance and Patient Satisfaction with Estradiol Vaginal Tablets in Postmenopausal Women Previously Treated with Another Local Estrogen Therapy," offers insight into reasons that various treatment regimens for vaginal atrophy...

2013-01-31 08:30:13

PRINCETON, N.J., Jan. 31, 2013 /PRNewswire/ -- Novo Nordisk (NYSE: NVO), a global healthcare company with 90 years of innovation and leadership in diabetes care, announced the promotion of four corporate vice presidents to senior vice presidents. Effective March 1, 2013, the following members of the U.S. Executive Team will assume the title of senior vice president in their respective areas: Andy Ajello, U.S. National Diabetes Sales; Camille Lee, U.S. Diabetes Marketing; Alan Moses, MD,...

2013-01-22 08:30:40

PRINCETON, N.J., Jan. 22, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog(®) Community Star contest. As part of the program, type 2 diabetes patients successfully managing their blood sugar with NovoLog(®) (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and tell us how they're giving back to their local communities. To view the multimedia assets associated with this release, please click:...

2013-01-17 08:26:43

PRINCETON, N.J., Jan. 17, 2013 /PRNewswire/ -- Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 90 years of innovation and leadership in diabetes care, has been ranked 48 in FORTUNE Magazine's 2013 "100 Best Companies to Work For" list. This year's ranking marks the fifth consecutive year Novo Nordisk has earned the honor of being a top workplace--a testament to the passion of employees dedicated to improving diabetes care and the lives of patients with chronic diseases. "Novo...

2012-05-08 14:21:50

PRINCETON, N.J., May 8, 2012 /PRNewswire/ -- Novo Nordisk Inc., a global healthcare company with 89 years of innovation and leadership in diabetes care, announced today that Robert Clark will be joining the company's U.S. business as Vice President, Regulatory Affairs starting May 14. (Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO) Clark will lead Novo Nordisk's U.S. regulatory team, and maintain relationships with key individuals and agencies outside of Novo Nordisk that play...

2012-04-27 02:25:36

PRINCETON, N.J., April 27, 2012 /PRNewswire/ -- Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, today announced plans for a nearly 15 percent expansion of its U.S. work force in 2012. Novo Nordisk has experienced solid growth over the past five years, with an approximately 10 percent increase in U.S. staff per year across a number of specialties. Recruiting is expected to start immediately. (Logo:...

2012-04-26 02:29:58

PRINCETON, N.J., April 26, 2012 /PRNewswire/ -- Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, was named as one of the "Best Places to Work in New Jersey" by NJBIZ, the state's largest weekly business journal. This is the eighth time Novo Nordisk has appeared on the annual list. Earlier this year, Novo Nordisk was recognized for the fourth straight year as one of FORTUNE Magazine's "100 Best Companies to Work For."...